Search Results - "Juan Julio Kassack-Ipiña"
-
1
Dasatinib or imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: 2-year follow-up from a randomized phase 3 trial (DASISION)
Published in Blood (02-02-2012)“…Dasatinib is a highly potent BCR-ABL inhibitor with established efficacy and safety in imatinib-resistant/-intolerant patients with chronic myeloid leukemia…”
Get full text
Journal Article -
2
Effect of metformin on the survival of patients with ALL who express high levels of the ABCB1 drug resistance gene
Published in Journal of translational medicine (03-09-2018)“…In acute lymphoblastic leukemia (ALL), high ABCB1 gene expression has been associated with treatment resistance, which affects patient prognosis. Many…”
Get full text
Journal Article -
3
Effect of metformin added to chemotherapy on the survival of patients with acute lymphoblastic leukemia
Published in Revista medíca de Chile (01-07-2018)“…Metformin has antineoplastic and cancer protective effects in vitro, sensitizing leukemia cells to chemotherapeutic agents, inducing apoptosis and cell cycle…”
Get full text
Journal Article -
4
Comparison of the Hyper-CVAD with an institutional regimen for the treatment of acute lymphoblastic leukemia in adults in a hospital of Mexico
Published in Revista peruana de medicina experimental y salud pública (01-07-2014)“…In order to assess the mortality and toxicity of the Hyper-CVAD protocol used as first-line treatment of acute lymphoblastic leukemia, a retrospective cohort…”
Get full text
Journal Article -
5
Treatment Experience of Acute Lymphoblastic Leukemia with Hgm/LAL07 Regimen at Hospital General De Mexico
Published in Blood (03-12-2015)“…Introduction Acute lymphoblastic leukemia is a lymphoproliferative malignancy characterized by an uncontrolled growth of lymphoid progenitors of B or T…”
Get full text
Journal Article -
6
A Decade Of Imatinib As First-Line Treatment Of Chronic Myeloid Leukemia: A Single - Latin American Institution Experience
Published in Blood (15-11-2013)“…Targeted therapy commenced against Chronic Myeloid Leukemia (CML) with the development of small-molecule tyrosine kinase inhibitors (TKIs), since its approval…”
Get full text
Journal Article -
7
Detection Of Mutations In The Isocitrate Dehydrogenase Genes (IDH1/IDH2) Using castPCR TM In Patients With AML And Their Clinical Impact In Mexico City
Published in OncoTargets and therapy (01-10-2019)“…Approximately 40-50% of patients with acute myeloid leukaemia (AML) have been reported to present with a normal karyotype and a variable disease-free period,…”
Get full text
Journal Article -
8
Efecto de la metformina en la etapa de inducción en pacientes con leucemia aguda linfoblástica y su impacto clínico en la supervivencia
Published in Revista medíca de Chile (01-07-2018)Get full text
Journal Article -
9
Comparación del hyper-CVAD con un régimen institucional en el tratamiento de la leucemia linfoblástica aguda del adulto en un hospital de México
Published in Revista peruana de medicina experimental y salud pública (25-09-2014)“…Con el objetivo de evaluar la mortalidad y toxicidad del protocolo Hyper-CVAD utilizado como primera línea de tratamiento de la leucemia linfoblástica aguda se…”
Get full text
Journal Article -
10
Comparación del Hyper-CVAD con un régimen institucional en el tratamiento de la leucemia linfoblástica aguda del adulto en un hospital de México
“…Con el objetivo de evaluar la mortalidad y toxicidad del protocolo Hyper-CVAD utilizado como primera línea de tratamiento de la leucemia linfoblástica aguda se…”
Get full text
Journal Article -
11
Comparación del Hyper-CVAD con un régimen institucional en el tratamiento de la leucemia linfoblástica aguda del adulto en un hospital de México
“…Con el objetivo de evaluar la mortalidad y toxicidad del protocolo Hyper-CVAD utilizado como primera línea de tratamiento de la leucemia linfoblástica aguda se…”
Get full text
Journal Article